Literature DB >> 33197620

Human-based evidence for the therapeutic potential of arginase inhibitors in cardiovascular diseases.

Johnny Moretto1, Marc Pudlo2, Céline Demougeot2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33197620     DOI： 10.1016/j.drudis.2020.11.005

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN： 1359-6446            Impact factor:   7.851


× No keyword cloud information.
  2 in total

Review 1.  Neutrophil degranulation and myocardial infarction.

Authors:  Nan Zhang; Xiahenazi Aiyasiding; Wen-Jing Li; Hai-Han Liao; Qi-Zhu Tang
Journal:  Cell Commun Signal       Date:  2022-04-11       Impact factor: 5.712

2.  New Insights into the Determinants of Specificity in Human Type I Arginase: Generation of a Mutant That Is Only Active with Agmatine as Substrate.

Authors:  María-Soledad Orellana; Gonzalo A Jaña; Maximiliano Figueroa; José Martínez-Oyanedel; Fabiola E Medina; Estefanía Tarifeño-Saldivia; Marcell Gatica; María Ángeles García-Robles; Nelson Carvajal; Elena Uribe
Journal:  Int J Mol Sci       Date:  2022-06-09       Impact factor: 6.208
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.